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Abstract We show that in a series of eight breast cancer cell
lines, a direct relationship exists between the overall DNA
demethylation and the percentage of rearranged chromosomes,
except for cell lines with a highly rearranged genome which can
be weakly demethylated. A real time fluorescent detection
method was used to quantify by reverse transcription-PCR the
expression of the DNA methyltransferase 1 and of the newly
discovered DNA demethylase. The overall DNA methylation
status seems to result from a complex interplay between the
expression of these two genes. Our results suggest that in these
tumor cells, the overall DNA demethylation is implicated in one
of the mechanisms at the origin of the genome instability and that
besides the role of the DNA methyltransferase 1, that of the
DNA demethylase may be essential in the control of DNA
methylation.
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1. Introduction
Mammalian DNA methylation has been proposed to be an
important factor in maintaining genome stability. This notion
is based on the observation that genomic aberrations are re-
currently associated with global DNA demethylation. For ex-
ample, in cells treated with the demethylating agent 5-azacyt-
idine [1], in lymphoblastoid cell lines [2] and in cells from
patients with the disease ICF (immunode¢ciency, centromeric
instability and facial abnormalities) [3], a direct relationship
was found between DNA demethylation and elongations,
breakages and rearrangements involving the juxtacentromeric
heterochromatic region of chromosomes 1 and 16. In addition
for several types of cancer, DNA demethylation has been
implied as being an important factor in the formation of re-
arranged chromosomes involving the same regions, but up
until now, no direct demonstration of this has been provided
[4,5]. A role for DNA methylation in the stability of other
chromosome regions has also been established. In human tu-
mor cell lines from the colon, a relationship was found be-
tween a defect in the capacity of DNA methylation, the pro-
¢ciency of the mismatch repair mechanisms and the presence
of chromosome rearrangements [6]. Finally, in the highly de-
methylated genome of murine embryonic stem cells nullizy-
gous for the DNA methyltransferase 1 (Dnmt1), the major
cause of the high rate of deletions observed in an integrated
viral thymidine kinase transgene was either mitotic recombi-
nation or chromosome loss [7]. These data all suggest that
DNA methylation plays an important role in maintaining
genome stability, but the mechanisms which drive the forma-
tion of the rearranged chromosomes remain to be established.
The mechanisms regulating DNA methylation in mamma-
lian cells are poorly understood, although several of the par-
ticipants have now been identi¢ed. As demonstrated by gene
knock-out experiments in mice, Dnmt1 is a major determinant
of DNA methylation [8]. Overexpression of the human DNA
methyltransferase 1 (DNMT1) was previously observed in tu-
mors and in tumor cell lines (reviewed in [9]). Although this
increased expression could mainly re£ect enhanced cell prolif-
eration, when normalized with the expression of genes that
measure cell proliferation, little di¡erences in the amounts
of DNMT1 mRNA were observed [10,11]. A second potential
DNA methyltransferase has been isolated (DNMT2), but its
ability to methylate DNA has not yet been shown [12]. More
recently, another group of DNA methyltransferases
(DNMT3A and 3B) was isolated [13]. DNMT3A was consid-
ered as signi¢cantly overexpressed in a series of tumors [14]
although no di¡erence of expression was found between colon
tumors and normal tissues in another study [10]. In this latter
study, no relationship was found between the expression of
DNMT1, DNMT3A or DNMT3B and the methylation status
of CpG islands. Adding to the complexity of the system, some
DNA methyltransferases display several forms, possibly ex-
pressed in a tissue-speci¢c manner, di¡ering either in their
translation start site or their splicing sites [14^16]. In contrast
to the numerous DNA methyltransferases cloned, a DNA
demethylase was only recently cloned [17]. However, the im-
plication of this DNA demethylase in the establishment and
maintenance of DNA methylation in normal and tumor cells
is not yet known.
In this study, we investigate the relationship between overall
DNA methylation, the presence of rearranged chromosomes
and the expression of DNMT1 and DNA demethylase in
breast cancer cell lines.
2. Material and methods
2.1. Biological material
Seven breast cancer cell lines (MDA-MD-134 (passage 33), MDA-
MB-231 (passage 24), MDA-MB-361 (passage 47), SK-BR-3 (passage
24), BT-20 (passage 286), ZR-75-1 (passage 83), T-47-D (passage 76))
were obtained from the American Type Culture Collection. H-466B
has previously been described [18]. Cells were grown for a few more
passages in DMEM medium supplemented with 10% fetal bovine
serum and collected during the growth phase before con£uence.
Five breast tissue samples were obtained from plastic mastectomy
with informed consent of the donors.
2.2. DNA methylation measurement
The methylation status of total genomic DNA was established as
previously described [19]. DNA was digested by MspI or HpaII, sep-
arated on agarose gel and blotted. Hybridization was performed with
32P-labelled total DNA from human placenta. For each lane, the ratio
r between the radioactivity present between the molecular weights of
1.8 and 2.9 kb and the total of the smear was calculated. The ratio R,
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between the r obtained for MspI and HpaII digestions was calculated
for each DNA sample. The total DNA methylation (13R) theoret-
ically ranges from one (fully methylated DNA) to zero (fully de-
methylated DNA).
2.3. Cytogenetic analysis
The percentage of rearranged chromosomes, including all structural
abnormalities, was determined on R-banded chromosomes1 as de-
scribed [20]
2.4. Expression analysis
A real time £uorescent detection method [21] was used to quantify
the mRNA expression of DNMT1 and of the DNA demethylase by
reverse transcription-polymerase chain reaction (RT-PCR). Total
RNA was prepared with the Trizol reagent kit (Life Technologies).
Residual DNA contamination was removed using the High Pure
RNA isolation kit (Roche). Reverse transcription was performed us-
ing the Superscript II enzyme (Life Technologies) with 2 Wg of total
RNA, 200 ng of oligo-d(T) and 0.5 mM of each dNTP. Primers for
PCR were chosen with the assistance of the computer program Primer
Express (Perkin-Elmer Applied Biosystems). Primers were purchased
from Oligo Express (France). The following primers were used:
(1) DNA methyltransferase 1 [22], 5P-TGGAGAGAAGCTCC-
CTCTGTTC-3P, 5P-CCGAGCTCAACCTGGTTATGTT-3P which
yielded a 119 bp fragment (2) DNA demethylase [17], 5P-GAATGAA-
CAGCCACGTCAGCTT-3P, 5P-GCTACCTGGACCAACTCCTT-
GA-3P which generated a 127 bp fragment, (3) histone H4, partially
degenerated primers were used taking into account the published se-
quences for the di¡erent forms (GenBank released 104), 5P-ATYT-
AYGAGGAGACYCGCG-3P, 5P-CCATGGCKGTGACYGTCTT-3P
which gave a 107 bp fragment.
The target cDNAs were ampli¢ed separately by PCR using a Gene-
Amp 5700 sequence detection system and a SYBR Green PCR kits
(Perkin-Elmer Applied Biosystems). The detection method was based
on the property of the SYBR Green dye which £uoresces when bound
to double-stranded DNA. At each cycle, the amount of ampli¢ed
product was measured by monitoring the green light emitted. The
PCR reactions were performed in MicroAmp Optical tubes (Perkin-
Elmer Applied Biosystems) positioned in a 96 well support. The re-
action mixture (25 Wl) contained the reverse transcription product, 250
nM of each primer, 200 WM of each dATP, dCTP and dGTP, 400 WM
dUTP, 4 mM MgCl2, 5 U of Amplitaq Gold DNA polymerase, 1 U
of AmpErase uracil N-glycosylase and 1USYBR Green PCR bu¡er
containing the SYBR Green dye. Thermal cycling consisted of one
cycle at 50‡C for 2 min and at 95‡C for 10 min followed by 40 cycles
at 60‡C for 1 min and 95‡C for 15 s. Each assay included a standard
curve, a no-template control and the tested samples, all in duplicate.
All the primer pairs used gave an e⁄ciency of ampli¢cation higher
than 95% (100% corresponding to doubling of the ampli¢ed product
at each cycle). Two reverse transcriptions followed by at least two
PCR ampli¢cations were performed for each sample. Control of the
products of ampli¢cation by gel electrophoresis and by determining
the melting curves demonstrated that the expected products were spe-
ci¢cally ampli¢ed. For each sample (corresponding to 10 ng of total
RNA), the cycle number at which the £uorescent signal crossed a
threshold in the exponential phase of the PCR reaction was measured
and compared to the standard curve. The standard curve was con-
structed with serial dilutions of reverse transcription products corre-
sponding to 0.1, 1, 10 and 100 ng of total RNA from a reference cell
line (MDA-MB-134). The expression of the other cell lines was com-
pared to the standard curve and reported in equivalent quantity of
total RNA from the reference cell line. The normalization of RNA
amounts was performed using histone H4 expression analyzed with
the same procedure. The expression ratios DNA demethylase 1/his-
tone H4 and DNMT1/histone H4 were calculated. This method did
not give the absolute quantity of mRNA nor did it allow for a quan-
titative gene to gene comparison of the expression. In contrast, the
method did allow for each gene a comparison between various cell
lines.
3. Results
The karyotypes of the eight breast cancer cell lines were
established. Various types of chromosome rearrangement
were observed (deletions, fusions, homogeneous staining re-
gions). No recurrent site of instability was found except for
the juxtacentromeric region of chromosome 1, which was im-
plicated in a chromosome rearrangement in ¢ve of the eight
cell lines (not shown). For all cell lines, the total DNA meth-
ylation was determined and reported as a function of the
percentage of rearranged chromosomes (Fig. 1). For six cell
lines, (MDA-MB-134, ZR-75-1, H-466B, T-47-D, MDA-MB-
231 and SK-BR-3), a linear decrease of the total DNA meth-
ylation was observed as a function of the percentage of rear-
ranged chromosomes. In this group, lower levels of methyla-
tion were correlated with a higher percentage of rearranged
chromosomes. Two of the cell lines analyzed did not follow
this relationship. For MDA-MB-361 and BT-20, a highly re-
arranged genome was associated with a weakly demethylated
DNA. The level of methylation for some of the cell lines
(MDA-MB-134, MDA-MB-361 and BT-20) was not signi¢-
cantly di¡erent from that found in normal breast tissues,
Fig. 1. Relationships between the total DNA methylation status and
the percentage of rearranged chromosomes in eight breast cancer
cell lines. Values of total DNA methylation for cell lines are the
mean values of at least three independent measurements. For nor-
mal breast tissues (normal breast), the mean value established with
¢ve unrelated samples analyzed at least twice is presented. Total
DNA methylation values theoretically range from one (fully methyl-
ated DNA) to zero (fully demethylated DNA), experimental varia-
tions were þ 0.03.1 Karyotypes are available on request.
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whereas the most demethylated cases observed in this study
reached the highest values of demethylation reported in cer-
tain breast tumors or in transformed lymphoblastoid cells
[2,19]. No relation was found between DNA methylation
and the number of chromosomes (not shown).
The quantitative evaluation of DNMT1 expression has led
to con£icting results [9]. However, experiments employing
RNAse protection and quantitative RT-PCR [10,11] have
demonstrated that relevant results can be obtained when the
expression is normalized with a cell proliferation-associated
gene. The cell proliferation dependence of the DNA demethyl-
ase is not known, but assuming that its behavior could be
similar to that of DNMT1, we retained histone H4 as the
normalization gene. Therefore, we analyzed the expression
of DNMT1 and DNA demethylase by real time RT-PCR.
The levels of expression found, normalized to that of histone
H4, are reported as a function of the total DNA methylation
(Fig. 2). Two highly rearranged cell lines (MDA-MB-361 and
BT-20) displayed at the same time low DNA demethylation
and a low expression of the two genes. These low levels of
expression were also found in normal breast tissue. For ¢ve of
the six cell lines for which the DNA methylation was corre-
lated with percentage of rearranged chromosomes (MDA-
MB-231, T-47-D, H-466B, ZR-75-1, MDA-MB-134), the in-
crease in the expression of both DNMT1 and DNA demethyl-
ase was associated with an increase in the total DNA meth-
ylation. For example, the weakly demethylated cell line
MDA-MB-134 had a level of expression of the two genes 5^
10 times higher than normal breast tissue. The sixth cell line
(SK-BR-3) was strongly demethylated, had a low expression
of DNMT1 and a level of expression of the DNA demethylase
as high as MDA-MB-134. No relation was found between the
expression of DNMT1 (localized at 19p13.3p13.2 [22]) or of
the DNA demethylase (18q21.1 [17]) and the gain or loss of
the corresponding chromosome arm (not shown).
4. Discussion
In the breast cancer cell lines studied here, the levels of
DNA methylation were very widespread. The actual methyl-
ation status of these cell lines may be the addition of events
that occurred during the development of the original tumor
and in culture. Despite this complex situation, distinct behav-
iors could be observed from cell line to cell line.
Two cell lines with highly rearranged genomes (MDA-MB-
361 and BT-20) displayed at the same time a low DNA de-
methylation and a low expression of DNMT1 and of the
DNA demethylase. Similar low levels of expression were
found in the normal breast tissue. The concomitant low level
of expression of the two genes appears su⁄cient to maintain a
normal or near normal level of global methylation of the
genome. The similarity in expression between the normal tis-
sue and the highly rearranged cell lines suggests that in these
later cases, the DNA methylation mechanisms were not per-
turbated and that DNA methylation was not involved in their
karyotype evolution. In MDA-MB-134, ZR-75-1, H-466B, T-
47-B, MDA-MB-231 and SK-BR-3 cells, the linear relation-
ship between the changes in overall DNA demethylation and
the percentage of rearranged chromosome suggests a contri-
bution of DNA hypomethylation in the formation of chromo-
some aberrations. The widespread repartition of the sites of
breakage indicates a global instability of the genome which is
at the origin of the rearranged chromosomes selected during
cell transformation. The recurring involvement of the juxta-
centromeric region of chromosome 1 in rearrangements has
already been established in breast cancer cells. This instability
could be related to the demethylation of the classical satellite
2 localized in this region [2^5]. The levels of expression of
DNMT1 and of the DNA demethylase were low in three of
these cell lines (SK-BR-3, MDA-MB-231 and T-47-D). A high
up-regulation of the DNA demethylase, without concomitant
DNMT1 overexpression, was associated with a low methyla-
tion of the DNA (SK-BR-3), indicating that the demethylase
activity may control the global methylation level. Moreover,
even a weak overexpression of the DNA demethylase seems
su⁄cient to exceed the methylation capacity of the cells
(MDA-MB-231, T-47-D). In the case of DNMT1 overexpres-
sion (H-466B, ZR-75-1, MDA-MB-134), both DNA de-
methylase expression and DNA methylation followed the level
of DNMT1 expression. Thus in these cases, the increase in the
demethylation activity that could be linked to the up-regula-
tion of the DNA demethylase was exceeded by the overex-
pression of the DNA methyltransferase. In this group of
breast cancer cell lines, total DNA methylation seems to result
from an interplay between the expression of DNMT1 and
DNA demethylase. However, the level of mRNA expression
of either of these genes could be by itself unequivocally asso-
ciated with the methylation status of the genome. Other fac-
tors have to be considered, such as factors involved in the
post-transcriptional regulation of the genes and other proteins
engaged in the methylation/demethylation process or in the
modulation of the accessibility of DNA.
Fig. 2. DNMT1 (a) and DNA demethylase (b) expression in eight
breast cancer cell lines. RNA expression was measured by quantita-
tive real time RT-PCR. Expressions were normalized using histone
H4. The ratios between expression of DNMT1 or DNA demethylase
and histone H4 were plotted as a function of the total DNA meth-
ylation (see Fig. 1). The name of the cell line refers to the expres-
sion of the two genes plotted at the same horizontal level. The val-
ues for normal breast are the mean established for ¢ve unrelated
samples. Each point was the mean of at least four analyses (two re-
verse transcriptions followed by two PCRs). Ratio variations were
in a þ 0.3 range.
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We conclude that overall DNA demethylation is implicated
in one of the mechanisms at the origin of genome instability in
breast cancer cells and that besides the role of DNA methyl-
transferase 1, that of the newly discovered DNA demethylase
may be essential in the control of DNA methylation in these
tumor cells.
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